Morris J. Birnbaum

Dr. Morris J.
Birnbaum is a Chief Executive & Scientific Officer at Baseline Therapeutics, Inc. and an Independent Director at NorthSea Therapeutics BV.
He is on the Board of Directors at NorthSea Therapeutics BV and Cerevel Therapeutics LLC.
Dr. Birnbaum was previously employed as an Independent Director by Cerevel Therapeutics Holdings, Inc., a Member by American Society for Clinical Investigation, a Member by Association of American Physicians, an Associate Professor by Harvard Medical School, an Associate Dean-Biomedical Cores by Howard Hughes Medical Institute, Inc., an Associate Director by Institute For Diabetes, Obesity & Metabolism, a Professor by Perelman School of Medicine, and a Chief Scientific Officer-Internal Medicine & SVP by Pfizer Inc. He received his undergraduate degree from Brown University and a doctorate degree from Brown University.